Log in to save to my catalogue

Biocatalytic strategy for the construction of sp3-rich polycyclic compounds from directed evolution...

Biocatalytic strategy for the construction of sp3-rich polycyclic compounds from directed evolution...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11088497

Biocatalytic strategy for the construction of sp3-rich polycyclic compounds from directed evolution and computational modelling

About this item

Full title

Biocatalytic strategy for the construction of sp3-rich polycyclic compounds from directed evolution and computational modelling

Publisher

London: Nature Publishing Group UK

Journal title

Nature chemistry, 2024-05, Vol.16 (5), p.817-826

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Catalysis with engineered enzymes has provided more efficient routes for the production of active pharmaceutical agents. However, the potential of biocatalysis to assist in early-stage drug discovery campaigns remains largely untapped. In this study, we have developed a biocatalytic strategy for the construction of
sp
3
-rich polycyclic co...

Alternative Titles

Full title

Biocatalytic strategy for the construction of sp3-rich polycyclic compounds from directed evolution and computational modelling

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11088497

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11088497

Other Identifiers

ISSN

1755-4330,1755-4349

E-ISSN

1755-4349

DOI

10.1038/s41557-023-01435-3

How to access this item